Literature DB >> 23588323

Clinical pharmacology quality assurance for HIV and related infectious diseases research.

R DiFrancesco1, K Tooley, S L Rosenkranz, S Siminski, C R Taylor, P Pande, G D Morse.   

Abstract

Entities:  

Mesh：

Year:  2013        PMID： 23588323      PMCID： PMC3970711          DOI： 10.1038/clpt.2013.62

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN： 0009-9236            Impact factor:   6.875


× No keyword cloud information.
  5 in total

Review 1.  Topical microbicides to prevent HIV: clinical drug development challenges.

Authors:  Craig W Hendrix; Ying Jun Cao; Edward J Fuchs
Journal:  Annu Rev Pharmacol Toxicol       Date:  2009       Impact factor: 13.820

2.  Prevention of HIV-1 infection with early antiretroviral therapy.

Authors:  Myron S Cohen; Ying Q Chen; Marybeth McCauley; Theresa Gamble; Mina C Hosseinipour; Nagalingeswaran Kumarasamy; James G Hakim; Johnstone Kumwenda; Beatriz Grinsztejn; Jose H S Pilotto; Sheela V Godbole; Sanjay Mehendale; Suwat Chariyalertsak; Breno R Santos; Kenneth H Mayer; Irving F Hoffman; Susan H Eshleman; Estelle Piwowar-Manning; Lei Wang; Joseph Makhema; Lisa A Mills; Guy de Bruyn; Ian Sanne; Joseph Eron; Joel Gallant; Diane Havlir; Susan Swindells; Heather Ribaudo; Vanessa Elharrar; David Burns; Taha E Taha; Karin Nielsen-Saines; David Celentano; Max Essex; Thomas R Fleming
Journal:  N Engl J Med       Date:  2011-07-18       Impact factor: 91.245

Review 3.  Pharmacological considerations for tenofovir and emtricitabine to prevent HIV infection.

Authors:  Peter L Anderson; Jennifer J Kiser; Edward M Gardner; Joseph E Rower; Amie Meditz; Robert M Grant
Journal:  J Antimicrob Chemother       Date:  2010-11-30       Impact factor: 5.790

Review 4.  Antiretroviral bioanalysis methods of tissues and body biofluids.

Authors:  Robin DiFrancesco; Getrude Maduke; Rutva Patel; Charlene R Taylor; Gene D Morse
Journal:  Bioanalysis       Date:  2013-02       Impact factor: 2.681

5.  Global HIV/AIDS Clinical and Translational Pharmacology.

Authors:  Gene D Morse; Gary Maartens; Charles Chiedza Maponga; Qing Ma
Journal:  AIDS Res Treat       Date:  2012-07-18
  5 in total
  41 in total

1.  Development and validation of an assay to analyze atazanavir in human hair via liquid chromatography/tandem mass spectrometry.

Authors:  Nhi Phung; Karen Kuncze; Hideaki Okochi; Alexander Louie; Leslie Z Benet; Igho Ofokotun; David W Haas; Judith S Currier; Tariro D Chawana; Anandi N Sheth; Peter Bacchetti; Monica Gandhi; Howard Horng
Journal:  Rapid Commun Mass Spectrom       Date:  2018-03-15       Impact factor: 2.419

2.  Simultaneous analysis of 11 medications for drug resistant TB in small hair samples to quantify adherence and exposure using a validated LC-MS/MS panel.

Authors:  Roy Gerona; Anita Wen; David Aguilar; Jamie Shum; Andrew Reckers; Peter Bacchetti; Monica Gandhi; John Metcalfe
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2019-07-23       Impact factor: 3.205

3.  Tail-phase safety, tolerability, and pharmacokinetics of long-acting injectable cabotegravir in HIV-uninfected adults: a secondary analysis of the HPTN 077 trial.

Authors:  Raphael J Landovitz; Sue Li; Joseph J Eron; Beatriz Grinsztejn; Halima Dawood; Albert Y Liu; Manya Magnus; Mina C Hosseinipour; Ravindre Panchia; Leslie Cottle; Gordon Chau; Paul Richardson; Mark A Marzinke; Susan H Eshleman; Ryan Kofron; Adeola Adeyeye; David Burns; Alex R Rinehart; David Margolis; Myron S Cohen; Marybeth McCauley; Craig W Hendrix
Journal:  Lancet HIV       Date:  2020-06-01       Impact factor: 12.767

4.  Efavirenz Therapeutic Range in HIV-1 Treatment-Naive Participants.

Authors:  Cindy J Bednasz; Charles S Venuto; Qing Ma; Eric S Daar; Paul E Sax; Margaret A Fischl; Ann C Collier; Kimberly Y Smith; Camlin Tierney; Yang Yang; Gregory E Wilding; Gene D Morse
Journal:  Ther Drug Monit       Date:  2017-12       Impact factor: 3.681

5.  Assessment of Nevirapine Prophylactic and Therapeutic Dosing Regimens for Neonates.

Authors:  Tim R Cressey; Baralee Punyawudho; Sophie Le Coeur; Gonzague Jourdain; Chalermpong Saenjum; Edmund V Capparelli; Kanokwan Jittayanun; Siriluk Phanomcheong; Anita Luvira; Thitiporn Borkird; Achara Puangsombat; Leon Aarons; Pra-Ornsuda Sukrakanchana; Saik Urien; Marc Lallemant
Journal:  J Acquir Immune Defic Syndr       Date:  2017-08-15       Impact factor: 3.731

6.  Antiretroviral drug concentrations in hair are associated with virologic outcomes among young people living with HIV in Tanzania.

Authors:  Zachary J Tabb; Blandina T Mmbaga; Monica Gandhi; Alexander Louie; Karen Kuncze; Hideaki Okochi; Aisa M Shayo; Elizabeth L Turner; Coleen K Cunningham; Dorothy E Dow
Journal:  AIDS       Date:  2018-06-01       Impact factor: 4.177

7.  Tenofovir Exposure during Pregnancy and Postpartum in Women Receiving Tenofovir Disoproxil Fumarate for the Prevention of Mother-to-Child Transmission of Hepatitis B Virus.

Authors:  Tim R Cressey; Linda Harrison; Jullapong Achalapong; Prateep Kanjanavikai; Orada Patamasingh Na Ayudhaya; Prateung Liampongsabuddhi; Thitiporn Siriwachirachai; Chaiwat Putiyanun; Pornnapa Suriyachai; Camlin Tierney; Nicolas Salvadori; Dujrudee Chinwong; Luc Decker; Yardpiroon Tawon; Trudy V Murphy; Nicole Ngo-Giang-Huong; George K Siberry; Gonzague Jourdain
Journal:  Antimicrob Agents Chemother       Date:  2018-11-26       Impact factor: 5.191

8.  Pharmacokinetics of Once-Daily Darunavir/Ritonavir With and Without Etravirine in Human Immunodeficiency Virus-Infected Children, Adolescents, and Young Adults.

Authors:  Kajal B Larson; Tim R Cressey; Ram Yogev; Andrew Wiznia; Rohan Hazra; Patrick Jean-Philippe; Bobbie Graham; Amy Gonzalez; Paula Britto; Vincent J Carey; Edward P Acosta
Journal:  J Pediatric Infect Dis Soc       Date:  2015-01-28       Impact factor: 3.164

9.  CYP2B6*6 and CYP2B6*18 Predict Long-Term Efavirenz Exposure Measured in Hair Samples in HIV-Positive South African Women.

Authors:  Carola R Röhrich; Britt I Drögemöller; Ogechi Ikediobi; Lize van der Merwe; Nelis Grobbelaar; Galen E B Wright; Nathaniel McGregor; Louise Warnich
Journal:  AIDS Res Hum Retroviruses       Date:  2016-01-29       Impact factor: 2.205

10.  Rilpivirine Pharmacokinetics Without and With Darunavir/Ritonavir Once Daily in Adolescents and Young Adults.

Authors:  Marc Foca; Ram Yogev; Andrew Wiznia; Rohan Hazra; Patrick Jean-Philippe; Bobbie Graham; Paula Britto; Vincent J Carey; Jennifer King; Edward P Acosta; Tim R Cressey
Journal:  Pediatr Infect Dis J       Date:  2016-09       Impact factor: 2.129
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.